Previous 10 | Next 10 |
PressReach.com news releases related Pressreach.com news releases and Pressreach.com press releases from 12/14/22 02:21:56 on US and Canada Markets.
Broadcom ( NASDAQ:AVGO ) On Wednesday, semiconductor stocks in the S&P 500 were led higher by Broadcom ( NASDAQ:AVGO ), as the sector, along with the larger market, anticipated the most recent interest rate decision and forecast from the Federal Reserve ...
Even though the Federal Reserve’s decision on interest rates hung over Wall Street on Tuesday at lunchtime, there were still a few stocks that moved a lot because of news about those stocks. Donald Trump’s Digital World Acquisition ( NASDAQ:DWAC ) increased in value when...
After taking a fresh look at Netflix stock ( NASDAQ:NFLX ) content strategy, Jefferies comes away wary, especially as the new ad-supported tier is only now beginning to develop. In particular, it has given analyst Andrew Uerkwitz reason to believe that fourth-quarter subscriber growth may onl...
Apple ( NASDAQ:AAPL ) Morgan Stanley said on Wednesday that if Apple ( NASDAQ:AAPL ) were change its policy and start allowing third-party app stores on iPhones and iPads to comply with specific requirements in the European Union, the change would have ...
Elon Musk’s Twitter initiative, according to Loup Ventures analyst Gene Munster, puts Tesla ( NASDAQ:TSLA ) in danger because the EV manufacturer’s brand is heavily reliant on how the public views the billionaire. “Tesla’s trademark is Elon.” He need...
Elon Musk’s Twitter initiative, according to Loup Ventures analyst Gene Munster, puts Tesla ( NASDAQ:TSLA ) in danger because the EV manufacturer’s brand is heavily reliant on how the public views the billionaire. “Tesla’s trademark is Elon.” He need...
Elon Musk’s Twitter initiative, according to Loup Ventures analyst Gene Munster, puts Tesla ( NASDAQ:TSLA ) in danger because the EV manufacturer’s brand is heavily reliant on how the public views the billionaire. “Tesla’s trademark is Elon.” He need...
Moderna Stock ( NASDAQ:MRNA ) Merck ( NYSE:MRK ) and Moderna ( NASDAQ:MRNA ) announced that their mRNA cancer vaccine, mRNA-4157/V940, in combination with Keytruda, achieved the primary objective of a phase 2b trial in select patients with melanoma. Melan...
On Tuesday, Lucid stock opened higher , trading as high as $8.96 a share, but gains could not be maintained. During noon trading, the price of Lucid stock decreased by 0.3%. Electric car start-up In preparation for the growth of its product line, Lucid is working to secure sup...
On Tuesday, Lucid stock opened higher , trading as high as $8.96 a share, but gains could not be maintained. During noon trading, the price of Lucid stock decreased by 0.3%. Electric car start-up In preparation for the growth of its product line, Lucid is working to secure sup...
News, Short Squeeze, Breakout and More Instantly...
Trending Stock
5.51%Change Percent:
Trxade Group Inc Company Name:
MEDS Stock Symbol:
NASDAQ Market:
rx.trxade.com Website: